JB Chemical Plant in Gujarat, western India.
Gush medicine– Managed by Indian Billionaire Sibling Sudhir and Samir Mehta– Has actually accepted purchase risk in JB Chemicals and Pharmaceuticals in an offer of 11,910 crore (US$ 1.4 billion).
Gush Pharma will certainly purchase 46.4% of JB Pharma for Rs 1,600 per share and will certainly likewise purchase up to 2.8% of the shares from some workers at the very same cost. It will certainly after that make a deal to purchase 26% of the shares at Rs 1,639.18 each, hence paying a minor costs to the minority investors. According to the joint statement Launch on Sunday.
” This calculated uniformity even more reinforces our existence in the Indian pharmaceutical market and constructs a bigger international existence,” Samir Mehta, exec chairman of Gush Pharma, claimed in a declaration.
After the deal is finished, both firms will certainly combine with investors holding 100 shares of JB Pharma and obtain 51 Gush shares. These purchases are authorized by regulatory authorities.
The bargain enabled Gush Pharma to acquire a fast-growing pharmaceutical service in India. According to its internet site, JB Pharma was started in 1976 and creates a series of substance abuse in gastroenterology, high blood pressure, dermatology and diabetes mellitus. Since March 2025, the business (exports its items to over 40 nations consisting of the USA) climbed to Rs 6.6 crore.
” As we get in a brand-new phase with Gush Pharmaceuticals, we are positive that the mixed toughness of our company will certainly open extra possibilities to boost health care possibilities throughout the marketplace,” claimed Nikhil Chopra, Chief Executive Officer of JB Pharma.
According to the 100 wealthiest checklist launched by India Forbes Asia Last October. Much of their riches originates from Gush Pharma, the major business of the $4.9 billion (earnings) Gush Team. The 64-year-old business was started by the late daddy Uttambhai Nathalal Mehta, a previous sales person for Swiss pharmaceutical large Sandoz.
